By Michael C Perry
The Chemotherapy resource publication, Fourth Edition pulls jointly the entire present details at the chemotherapeutic administration of melanoma sufferers, together with selection of chemotherapeutic brokers, use of mixtures, and toxicity of person medicinal drugs. equipped by way of ailment website, the e-book brings jointly pharmacologic and sufferer administration details in a single resource that clinicians can seek advice for any query encountered within the supply of chemotherapy.
This up-to-date Fourth version contains new medicinal drugs in addition to new symptoms for older medications. content material has been streamlined to supply crucial info extra speedy for the busy practitioner. Plus, this variation is softcover for higher portability and convenience.
Read or Download The chemotherapy source book PDF
Similar oncology books
Energy Balance and Gastrointestinal Cancer
The gastrointestinal music presents one of many special platforms the place a number of malignancies, together with adenocarcinoma of the pancreas, esophagus and colon are every one linked to weight problems. This exact organization is roofed during this quantity of power stability and melanoma from the epidemiologic, biologic and power etiologic point of view.
Brain Metastases from Primary Tumors. Epidemiology, Biology, and Therapy
With an annual cost of greater than 12 million worldwide diagnoses and seven. 6 million deaths, the societal and financial burden of melanoma can't be overstated. mind metastases are the commonest malignant tumors of the vital fearful method, but their occurrence seems to be expanding despite the development of melanoma cures.
Branching Process Models of Cancer
This quantity develops effects on non-stop time branching techniques and applies them to check expense of tumor development, extending vintage paintings at the Luria-Delbruck distribution. to that end, the writer calculate the likelihood that mutations that confer resistance to remedy are current at detection and quantify the level of tumor heterogeneity.
- Pharmacotherapy Principles and Practice Study Guide
- Quick Reference for Otolaryngology: Guide for APRNs, PAs, and Other Healthcare Practitioners
- La casa della sapienza
- Angiogenesis Inhibition
Extra resources for The chemotherapy source book
Sample text
27. National Cancer Institute (USA). Surveillance, epidemiology and end results (SEER) program. 1974-1987. 45. Ludwig Breast Cancer Study Group. Combination adjuvant chemotherapy for nodepositive breast cancer. Inadequacy of a single perioperative cycle. N Engl J Med 1988; 319:677-683. 46. Vredenburgh JJ, Coniglio D, Broadwater G, et al. Consolidation with high-dose combination alkylating agents with bone marrow transplantation significantly improves disease-free survival in hormone-insensitive metastatic breast cancer in complete remission compared with intensive standard-dose chemotherapy alone.
138. Venturini M, Del Mastro L, Aitini E, et al. Dose-dense adjuvant chemotherapy in early breast cancer patients: results from a randomized trial. J Natl Cancer Inst 2005; 97:1724-1733. 103. Folkman J, Shing Y. Angiogenesis. J Biol Chem 1992;267:10931-10934. 139. Slamon DJ, Leyland-Jones B, Shak S, et al. Use of chemotherapy plus a monoclonal antibody against HER2 for 104. Norton L. Introduction to clinical aspects of preneoplasia: a mathematical relationship between stromal paracrine metastatic breast cancer that overexpresses HER2.
143. Gianni AM, Bregni M, Siena S, et al. High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphomas. N Engl J Med 199;336:1290-1297. 109. Heuser L, Spratt J, Polk H. Growth rates of primary breast cancer. Cancer 1979;43:1888-1894. 144. Valeriote F, van Putten L. Proliferation-dependent cytotoxicity of anticancer agents: a review. Cancer Res 110. Fisher B, Slack N, Katrych D, et al. Ten-year follow-up results in patients with carcinoma of the breast in a 1975;35:2619-2630.